Anixa Biosciences Establishes Cancer Business Advisory Board

SAN JOSE, Calif., Sept. 19, 2023 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has established a Cancer Business Advisory Board (CBAB), whose purpose is…

Click here to view original post